Short report: Performance evaluation of the Idylla™ KRAS and EGFR mutation tests on paraffin-embedded cytological NSCLC samples

BACKGROUND: Quick and reliable testing of EGFR and KRAS is needed in non-small cell lung cancer (NSCLC) to ensure optimal decision-making for targeted therapy. The Idylla™ platform was designed for Formalin-Fixed Paraffin-Embedded (FFPE) tissue sections but recently several studies were published th...

Descripción completa

Detalles Bibliográficos
Autores principales: Offerman, Saskia, Prinsen, Clemens F., Knol, Ageeth, Methorst, Natalie, Kamphorst, Jeanette, Niemantsverdriet, Maarten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330063/
https://www.ncbi.nlm.nih.gov/pubmed/34344387
http://dx.doi.org/10.1186/s13000-021-01121-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330063/
https://www.ncbi.nlm.nih.gov/pubmed/34344387
http://dx.doi.org/10.1186/s13000-021-01121-3

Ejemplares similares